|
OSBPL11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.57169999962059E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.18420000051157E-07 |
| Normal-vs-Stage2 |
1.559700E-04 |
| Normal-vs-Stage3 |
1.85139999997475E-07 |
| Normal-vs-Stage4 |
3.77409999918754E-08 |
| Stage1-vs-Stage2 |
8.387000E-01 |
| Stage1-vs-Stage3 |
3.992600E-01 |
| Stage1-vs-Stage4 |
6.242100E-02 |
| Stage2-vs-Stage3 |
4.766200E-01 |
| Stage2-vs-Stage4 |
1.190230E-01 |
| Stage3-vs-Stage4 |
3.133400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.66969999995759E-07 |
| Normal-vs-AfricanAmerican |
1.171120E-04 |
| Normal-vs-Asian |
5.99249999955198E-07 |
| Caucasian-vs-AfricanAmerican |
9.990400E-01 |
| Caucasian-vs-Asian |
5.781400E-01 |
| AfricanAmerican-vs-Asian |
6.806000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.46419999750236E-08 |
| Normal-vs-Female |
2.29300001208799E-09 |
| Male-vs-Female |
1.513810E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.31109999973656E-07 |
| Normal-vs-Age(41-60Yrs) |
2.94919999532794E-08 |
| Normal-vs-Age(61-80Yrs) |
2.74339999994933E-06 |
| Normal-vs-Age(81-100Yrs) |
3.129800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.946100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.115200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.137000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.018400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.738800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.610200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.366400E-01 |
| Classical-VS-Follicular |
8.123800E-01 |
| Classical-VS-Other |
1.773620E-01 |
| Classical-VS-Normal |
1.17509999997267E-06 |
| Tall-VS-Follicular |
5.733400E-01 |
| Tall-VS-Other |
3.736200E-01 |
| Tall-VS-Normal |
1.396060E-04 |
| Follicular-VS-Other |
9.199700E-02 |
| Follicular-VS-Normal |
6.14850000000278E-05 |
| Other-VS-Normal |
1.184860E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.07929995233292E-09 |
| Normal-vs-N1 |
7.94169999762673E-08 |
| N0-vs-N1 |
2.006600E-01 |
|
|
